HNPCC-associated pheochromocytoma: expanding the tumor spectrum
- PMID: 25872134
- PMCID: PMC4399001
- DOI: 10.1097/MPA.0000000000000311
HNPCC-associated pheochromocytoma: expanding the tumor spectrum
Conflict of interest statement
The Authors Declare No Conflict of Interest
Figures

References
-
- Hampel Heather, et al. Screening for the HNPCC (hereditary nonpolyposis colorectal cancer) New England Journal of Medicine. 2005;352(18):1851–1860. - PubMed
-
- Ligtenberg Marjolijn JL, et al. Heritable somatic methylation and inactivation of MSH2 in families with HNPCC due to deletion of the 3′ exons of TACSTD1. Nature genetics. 2008;41(1):112–117. - PubMed
-
- Vasen HFA, et al. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. Journal of Clinical Oncology. 2001;19(20):4074–4080. - PubMed
-
- Arnason Thomas, et al. Loss of expression of DNA mismatch repair proteins is rare in pancreatic and small intestinal neuroendocrine tumors. Archives of Pathology & Laboratory Medicine. 2011;135(12):1539–1544. - PubMed
-
- Kidd Mark, et al. Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors. Cancer. 2005;103(2):229–236. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical